Emerg Infect Dis. 2020 Dec;26(12):2835-2843. doi: 10.3201/eid2612.201664. Epub 2020 Aug 3.
Emerging coronaviruses are a global public health threat because of the potential for person-to-person transmission and high mortality rates. Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012, causing lethal respiratory disease in »35% of cases. Primate models of coronavirus disease are needed to support development of therapeutics, but few models exist that recapitulate severe disease. For initial development of a MERS-CoV primate model, 12 African green monkeys were exposed to 10, 10, or 10 PFU target doses of aerosolized MERS-CoV. We observed a dose-dependent increase of respiratory disease signs, although all 12 monkeys survived for the 28-day duration of the study. This study describes dose-dependent effects of MERS-CoV infection of primates and uses a route of infection with potential relevance to MERS-CoV transmission. Aerosol exposure of African green monkeys might provide a platform approach for the development of primate models of novel coronavirus diseases.
新兴冠状病毒对全球公共卫生构成威胁,因为它们具有人际传播的潜力和高死亡率。中东呼吸综合征冠状病毒(MERS-CoV)于 2012 年出现,导致约 35%的病例出现致命性呼吸道疾病。需要建立冠状病毒疾病的灵长类动物模型来支持治疗药物的开发,但目前仅有少数能重现严重疾病的模型。为了初步开发 MERS-CoV 灵长类动物模型,将 12 只非洲绿猴暴露于 10、10 或 10 PFU 剂量的雾化 MERS-CoV 中。尽管所有 12 只猴子在研究的 28 天期间均存活,但我们观察到呼吸道疾病体征与剂量呈依赖性增加。本研究描述了 MERS-CoV 感染灵长类动物的剂量依赖性效应,并使用了一种与 MERS-CoV 传播可能相关的感染途径。雾化暴露于非洲绿猴可能为新型冠状病毒疾病的灵长类动物模型的开发提供了一种平台方法。